The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
0405 ET – Fresenius Medical Care beat third-quarter revenue consensus expectations, but persistent lackluster same-market treatment growth in the U.S. remained a key challenge for shares, Citi analysts write. The German dialysis group’s path to sustainable 2% U.S. volume growth is uncertain, the analysts say. Sluggish flu vaccine uptake is another concern, although the flu season is in its early days, the analysts write. Risks include a slowdown in the group’s treatments exposed to Medicare and the effect of inflation on wages and disposable costs, the analysts add. Shares fall 6.1% to 42.90 euros. ([email protected])
Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
